Matches in SemOpenAlex for { <https://semopenalex.org/work/W165505087> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W165505087 endingPage "1405" @default.
- W165505087 startingPage "1405" @default.
- W165505087 abstract "Editor—The paper by de Abajo et al raises the possibility of an increased risk of upper gastrointestinal bleeding associated with selective serotonin reuptake inhibitors.1 The authors excluded patients with cancer, oesophageal varices, Mallory-Weiss disease, alcoholism, liver disease, and coagulopathies, but it is not clear if they excluded patients who were coprescribed antiulcer treatments. They do mention antecedents of upper gastrointestinal disorders as potential cofounders that were adjusted for.To investigate this issue further we examined a large prescription database provided by the general medical services in the Republic of Ireland. For November 1998 we determined the odds ratios to estimate the relative risk for the coprescription of antiulcer drugs (including H2 antagonists, proton pump inhibitors, and prostaglandin analogues but excluding antacids) with selective serotonin reuptake inhibitors and other antidepressants (table). We excluded people who were coprescribed aspirin, non-steroidal anti-inflammatory agents, or corticosteroids as this may have been cytoprotective coprescribing. This left a total of 95 929 patients for analysis, of whom 8921 received prescriptions for antiulcer drugs. There was a significant correlation between the prescribing of antidepressants of all types and antiulcer drugs. In the past, tricyclic antidepressants were used to treat peptic ulcer disease because of their antimuscarinic effects, but because of poor efficacy they are now not used for this. The newer selective serotonin reuptake inhibitors may have fewer antimuscarinic side effects, although they have gastrointestinal side effects such as vomiting, dyspepsia, and abdominal pain. Paradoxically, antidepressants (in particular, selective serotonin reuptake inhibitors) have been recommended in functional dyspepsia.2Coprescribing of antiulcer drugs with antidepressants may indicate patients with depression who have dyspeptic symptoms, an increased prevalence of peptic ulcer disease in patients with depression, or an increased prevalence of depression in patients with peptic ulcer disease. Whatever the true association between these conditions, an increased risk of bleeding from peptic ulcer disease would be expected on the basis of these data." @default.
- W165505087 created "2016-06-24" @default.
- W165505087 creator A5011484718 @default.
- W165505087 creator A5076716963 @default.
- W165505087 creator A5066915450 @default.
- W165505087 date "2000-05-20" @default.
- W165505087 modified "2023-10-14" @default.
- W165505087 title "Association between SSRIs and upper gastrointestinal bleeding" @default.
- W165505087 cites W2039130746 @default.
- W165505087 cites W2092902579 @default.
- W165505087 cites W2097732531 @default.
- W165505087 cites W2127949348 @default.
- W165505087 cites W2158787669 @default.
- W165505087 cites W2284627194 @default.
- W165505087 cites W2328493356 @default.
- W165505087 doi "https://doi.org/10.1136/bmj.320.7246.1405" @default.
- W165505087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1118062" @default.
- W165505087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10858059" @default.
- W165505087 hasPublicationYear "2000" @default.
- W165505087 type Work @default.
- W165505087 sameAs 165505087 @default.
- W165505087 citedByCount "32" @default.
- W165505087 countsByYear W1655050872012 @default.
- W165505087 countsByYear W1655050872015 @default.
- W165505087 countsByYear W1655050872017 @default.
- W165505087 countsByYear W1655050872019 @default.
- W165505087 countsByYear W1655050872020 @default.
- W165505087 countsByYear W1655050872022 @default.
- W165505087 crossrefType "journal-article" @default.
- W165505087 hasAuthorship W165505087A5011484718 @default.
- W165505087 hasAuthorship W165505087A5066915450 @default.
- W165505087 hasAuthorship W165505087A5076716963 @default.
- W165505087 hasBestOaLocation W1655050872 @default.
- W165505087 hasConcept C126322002 @default.
- W165505087 hasConcept C23123220 @default.
- W165505087 hasConcept C2522767166 @default.
- W165505087 hasConcept C2776345487 @default.
- W165505087 hasConcept C2778451229 @default.
- W165505087 hasConcept C41008148 @default.
- W165505087 hasConcept C71924100 @default.
- W165505087 hasConceptScore W165505087C126322002 @default.
- W165505087 hasConceptScore W165505087C23123220 @default.
- W165505087 hasConceptScore W165505087C2522767166 @default.
- W165505087 hasConceptScore W165505087C2776345487 @default.
- W165505087 hasConceptScore W165505087C2778451229 @default.
- W165505087 hasConceptScore W165505087C41008148 @default.
- W165505087 hasConceptScore W165505087C71924100 @default.
- W165505087 hasIssue "7246" @default.
- W165505087 hasLocation W1655050871 @default.
- W165505087 hasLocation W1655050872 @default.
- W165505087 hasLocation W1655050873 @default.
- W165505087 hasOpenAccess W165505087 @default.
- W165505087 hasPrimaryLocation W1655050871 @default.
- W165505087 hasRelatedWork W1506200166 @default.
- W165505087 hasRelatedWork W1995515455 @default.
- W165505087 hasRelatedWork W2048182022 @default.
- W165505087 hasRelatedWork W2080531066 @default.
- W165505087 hasRelatedWork W2604872355 @default.
- W165505087 hasRelatedWork W2748952813 @default.
- W165505087 hasRelatedWork W2899084033 @default.
- W165505087 hasRelatedWork W3031052312 @default.
- W165505087 hasRelatedWork W3032375762 @default.
- W165505087 hasRelatedWork W3108674512 @default.
- W165505087 hasVolume "320" @default.
- W165505087 isParatext "false" @default.
- W165505087 isRetracted "false" @default.
- W165505087 magId "165505087" @default.
- W165505087 workType "article" @default.